Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
1Dialysis Unit, ‘F. Lastaria’ Hospital, ASL Provincia di Foggia, Lucera (FG), 2‘Casa Sollievo della Sofferenza’ Hospital IRCCS, San Giovanni Rotondo (FG), 3Department of Nephrology and Dialysis, Brindisi, 4Department of Nephrology and Dialysis, Cerignola and 5Department of Biomedical Science, Chair of Nephrology, University of Foggia, Italy
Correspondence and offprint requests to: Filippo Aucella, MD, Dialysis Unit, ‘F. Lastaria’ Hospital, ASL della Provincia di Foggia, Viale Lastaria, 71036 Lucera (FG), Italy.Email: faucel1{at}alice.it
 |
Abstract |
|---|
Background. Patients undergoing chronic renal replacement therapy by haemodialysis (HD) suffer from chronic itching, the prevalence of which is very high. Many of the available treatment options are ineffective, but, as it has been shown that Polymethylmethacrylate based dialysis membranes (PMMA) membranes remove a wide range of ‘middle molecules’ and improve such long-term complications of HD as carpal tunnel syndrome and malnutrition, they may also have an effect on uraemic itching.
Methods. This prospective study enrolled eight patients undergoing standard HD with low-flux synthetic membranes and suffering from chronic itching. The strength and duration of itching was evaluated by the patients themselves at each study time-point using a visual analogue scale (VAS). After a baseline evaluation, the patients were switched to a PMMA membrane for 6 months during which their pre-dialysis haemoglobin, haematocrit, total protein, albumin, urea, creatinine, phosphate, intact parathyroid hormone (i-PTH), serum bile acid, ß2-microglobulin, C-reactive protein (CRP) levels, and eKt/V were measured, and any general complaints were recorded.
Results. The self-assessed VAS itching strength scores decreased by 15% after 1 month, 30% after 2 months, and 55% after 6 months, and itching duration decreased by, respectively, 10, 22 and 44% at the same time; 2 months after the end of the study, both scores had slightly increased. There were no statistically significant differences in the pre-dialysis blood chemistry values or eKt/V at the four study time-points, but ß2-microglobulin levels significantly decreased (P < 0.03); the decrease in CRP levels was not significant (P < 0.06). Furthermore, four patients showed a trend towards a lower incidence of intradialytic hypotension.
Conclusions. These findings support the hypothesis that a PMMA dialyser may improve renal itching in ESRD patients. This effect is not mediated by increased dialysis efficiency or an improvement in other biochemical parameters, but we can speculate that ionic substances may be directly or indirectly adsorbed into the polymer composition of BG-U series (PMMA membrane dialyser). We are currently undergoing further studies using a proteomic approach.
Keywords: haemodialysis; PMMA membrane; uraemic itching; visual analogue scale